LABORATORY CORP OF AMERICA HOLDINGS
For the period ended Mar 31, 2024. Filed Apr 30, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 30, 2024
LH$371.83+1.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $99.3 | $536.8 |
| Accounts receivable, net | 2,083.7 | 1,913.3 |
| Unbilled services | 120.4 | 185.4 |
| Supplies inventory | 475.0 | 474.6 |
| Prepaid expenses and other | 678.1 | 655.3 |
| Total current assets | 3,456.5 | 3,765.4 |
| Property, plant and equipment, net | 2,897.8 | 2,911.8 |
| Goodwill, net | 6,218.9 | 6,142.5 |
| Intangible assets, net | 3,394.1 | 3,342.0 |
| Joint venture partnerships and equity method investments | 17.7 | 26.9 |
| Other assets, net | 546.0 | 536.5 |
| Total assets | $16,531.0 | $16,725.1 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $695.5 | $827.5 |
| Accrued expenses and other | 649.3 | 804.0 |
| Unearned revenue | 377.5 | 421.7 |
| Short-term operating lease liabilities | 171.3 | 165.8 |
| Short-term finance lease liabilities | 6.4 | 6.4 |
| Short-term borrowings and current portion of long-term debt | 2,041.5 | 999.8 |
| Total current liabilities | 3,941.5 | 3,225.2 |
| Long-term debt, less current portion | 3,047.6 | 4,054.7 |
| Operating lease liabilities | 624.6 | 648.9 |
| Financing lease liabilities | 77.1 | 78.6 |
| Deferred income taxes and other tax liabilities | 397.2 | 417.9 |
| Other liabilities | 468.2 | 409.3 |
| Total liabilities | 8,556.2 | 8,834.6 |
| Commitments and contingent liabilities | ||
| Noncontrolling interest | 15.2 | 15.5 |
| Shareholders’ equity: | ||
| Common stock, $0.10 par value, 84.3 and 83.9 shares outstanding at March 31, 2024, and December 31, 2023, respectively | 7.7 | 7.7 |
| Additional paid-in capital | 82.0 | 38.4 |
| Retained earnings | 8,055.3 | 7,888.2 |
| Accumulated other comprehensive loss | (185.4) | (59.3) |
| Total shareholders’ equity | 7,959.6 | 7,875.0 |
| Total liabilities and shareholders’ equity | $16,531.0 | $16,725.1 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.